Ivan Bièche
Centre National de la Recherche Scientifique · 1,403 works · 35,673 citations · h-index 99
Top works
- Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.
- Genetic alterations in breast cancer
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection of gene amplification in breast cancer
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
- Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL , an Antisense Noncoding RNA Whose Expression Coclusters with ARF
- Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer
- The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
- Real-Time Reverse Transcription-PCR Assay for Future Management of ERBB2-based Clinical Applications
- Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
- Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
- ANRIL , a long, noncoding RNA, is an unexpected major hotspot in GWAS
- Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma
- Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
- TaqMan PCR-based Gene Dosage Assay for Predictive Testing in Individuals from a Cancer Family with INK4 Locus Haploinsufficiency
- SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
- Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.
- Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
- Two distinct regions involved in 1p deletion in human primary breast cancer.
- Quantification of estrogen receptor α and β expression in sporadic breast cancer